465 related articles for article (PubMed ID: 31841639)
1. Elevated Levels of Platelet Activating Factor and Its Acetylhydrolase Indicate High Risk of Kawasaki Disease.
Yi L; Zhang J; Zhong J; Zheng Y
J Interferon Cytokine Res; 2020 Mar; 40(3):159-167. PubMed ID: 31841639
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
Wu Y; Liu FF; Xu Y; Wang JJ; Samadli S; Wu YF; Liu HH; Chen WX; Luo HH; Zhang DD; Wei W; Hu P
Clin Exp Med; 2019 May; 19(2):173-181. PubMed ID: 30617865
[TBL] [Abstract][Full Text] [Related]
3. A polymorphism in plasma platelet-activating factor acetylhydrolase is involved in resistance to immunoglobulin treatment in Kawasaki disease.
Minami T; Suzuki H; Takeuchi T; Uemura S; Sugatani J; Yoshikawa N
J Pediatr; 2005 Jul; 147(1):78-83. PubMed ID: 16027700
[TBL] [Abstract][Full Text] [Related]
4. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
Front Immunol; 2021; 12():624802. PubMed ID: 33912155
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Wang JR; Zhao HZ; Chang LJ; Xu X; Gao Y; Li M; Kong QY; Wang MM; Zhao CF
Eur J Pediatr; 2023 Oct; 182(10):4399-4406. PubMed ID: 37480545
[TBL] [Abstract][Full Text] [Related]
6. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
Huang XB; Zhao S; Liu ZY; Xu YY; Deng F
Ann Med; 2023; 55(2):2264315. PubMed ID: 37870383
[TBL] [Abstract][Full Text] [Related]
7. [Predictive indicators and risk model construction for coronary artery lesions in Kawasaki disease children over 5 years old].
Zhang H; Zhang Y
Zhongguo Dang Dai Er Ke Za Zhi; 2024 May; 26(5):461-468. PubMed ID: 38802905
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
[TBL] [Abstract][Full Text] [Related]
9. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
Huiling L; Yaping L; Xiufen H
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
[TBL] [Abstract][Full Text] [Related]
10. Association between adropin and coronary artery lesions in children with Kawasaki disease.
Yang M; Pei Q; Zhang J; Weng H; Jing F; Yi Q
Eur J Pediatr; 2021 Jul; 180(7):2253-2259. PubMed ID: 33712900
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for coronary artery lesions in children with Kawasaki disease.
Duan J; Jiang H; Lu M
Arch Argent Pediatr; 2020 Oct; 118(5):327-331. PubMed ID: 32924395
[TBL] [Abstract][Full Text] [Related]
12. Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.
Zhang X; Ya-Wang Shao ; Ya-Lan Zhang ; Yi Liu
Heart Surg Forum; 2021 Jul; 24(4):E611-E618. PubMed ID: 34473042
[TBL] [Abstract][Full Text] [Related]
13. [Risk factors for coronary artery lesions secondary to Kawasaki disease in children].
Deng YC; Wang X; Tang XC; Huang CZ; Yang J; Mo LY
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep; 17(9):927-31. PubMed ID: 26412172
[TBL] [Abstract][Full Text] [Related]
14. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
[TBL] [Abstract][Full Text] [Related]
15. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
Peng Q; Zhou TF; Chen CH; Hua YM; Liu HM; Hong H; Zhang LY; Wu Q
Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):676-80. PubMed ID: 16191301
[TBL] [Abstract][Full Text] [Related]
16. Red blood cell distribution width and tumor necrosis factor-α for the early prediction of coronary artery lesion in Kawasaki disease: a retrospective study.
Li J; Li DE; Hu M; Huang H; Xu S; Li H
Eur J Pediatr; 2022 Mar; 181(3):903-909. PubMed ID: 34494160
[TBL] [Abstract][Full Text] [Related]
17. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
Shao S; Zhou K; Liu X; Liu L; Wu M; Deng Y; Duan H; Li Y; Hua Y; Wang C
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4210-e4220. PubMed ID: 33837779
[TBL] [Abstract][Full Text] [Related]
18. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
Hu P; Jiang GM; Wu Y; Huang BY; Liu SY; Zhang DD; Xu Y; Wu YF; Xia X; Wei W; Hu B
Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
[TBL] [Abstract][Full Text] [Related]
19. Z-score is a possible predictor of the risk of coronary artery lesion development in patients with Kawasaki disease in Japan.
Suzuki T; Kakimoto N; Tsuchihashi T; Suenaga T; Takeuchi T; Shibuta S; Kitano N; Suzuki H
Eur J Pediatr; 2021 Sep; 180(9):2797-2805. PubMed ID: 33763715
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma platelet activating factor, platelet activating factor acetylhydrolase levels and risk of coronary heart disease or blood stasis syndrome of coronary heart disease in Chinese: a case control study: a case-control study.
Zheng GH; Xiong SQ; Mei LJ; Chen HY; Wang T; Chu JF
Inflammation; 2012 Aug; 35(4):1419-28. PubMed ID: 22430230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]